https://doi.org/10.1158/1078-0432.ccr-16-2748
A
Anne F. Schott
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
181
Papers
11.6K
Citations
41
h-index
73
i10-index
Anne F. Schott is an academic researcher from University of Michigan. The author has contributed to research in topics: Advanced Breast Cancer Therapies & Cancer Treatment and Pharmacology & Breast Cancer Treatment Studies. The author has an h-index of 41, co-authored 154 publications.
ORCID: 0000-0001-9951-7269Papers by this author
worksPhase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2–Negative Metastatic Breast Cancer
2017 · Clinical Cancer Research · 236 citations
Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer
2014 · Clinical Cancer Research · 132 citations
https://doi.org/10.1158/1078-0432.ccr-14-1913
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)
2021 · Breast Cancer Research and Treatment · 97 citations
https://doi.org/10.1007/s10549-021-06367-5
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)
2021 · Breast Cancer Research and Treatment · 97 citations
https://doi.org/10.1007/s10549-021-06367-5
Clinical predictors of long-term survival in HER2-positive metastatic breast cancer
2016 · Breast Cancer Research and Treatment · 47 citations
https://doi.org/10.1007/s10549-016-3705-3
Image Registration for Quantitative Parametric Response Mapping of Cancer Treatment Response
2014 · Translational Oncology · 27 citations
https://doi.org/10.1593/tlo.14121
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat